Kymera Therapeutics, Inc. Profile Avatar - Palmy Investing

Kymera Therapeutics, Inc.

Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages …

Biotechnology
US, Watertown [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Kymera Therapeutics, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Kymera Therapeutics, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Kymera Therapeutics, Inc..

End of KYMR's Analysis
CIK: 1815442 CUSIP: 501575104 ISIN: US5015751044 LEI: - UEI: -
Secondary Listings
KYMR has no secondary listings inside our databases.